H.R. 10369

Net Effective Cost Transparency and Prescription Drug Affordability Act of 2026

4 cosponsors

Carol D. Miller
Jake Auchincloss
Lucy McBath
Rick W. Allen

Where it stands

Introduced Sep 14
Committee Now
House of Representatives —
Senate —
Law —

Introduced Sep 14
Committee Now
House of Representatives —
Senate —
Law —

Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. (Sep 14)

Votes

No roll-call votes yet.

Official summary

No official summary yet.

Text of the bill

Expand all

Sec. 1. Short title

Sec. 2. Medicare part D pharmacy benefit manager reforms

Sec. 3. Medicare Advantage pharmacy benefit manager requirements

Sec. 4. Commercial health plan transparency requirements